Literature DB >> 17306496

A non-transformed oligodendrocyte precursor cell line, OL-1, facilitates studies of insulin-like growth factor-I signaling during oligodendrocyte development.

William H Lagarde1, Robert Benjamin, Ann T Heerens, Ping Ye, Rick I Cohen, Billie M Moats-Staats, A Joseph D'Ercole.   

Abstract

The process by which oligodendrocyte progenitors differentiate into mature oligodendrocytes is complex and incompletely understood in part because of the paucity of oligodendrocyte precursors cell lines that can be studied in culture. We have developed a non-immortalized rat oligodendrocyte precursor line, called OL-1, which behaves in a fashion consistent with developing oligodendrocytes in vivo. This OL-1 line provides a model for the study of oligodendrocyte development and offers an alternative to the CG-4 cell line. When OL-1 cells are propagated in conditioned growth media, they have morphology consistent with immature oligodendrocytes and exhibit A2B5 antigen positive and myelin basic protein-negative immunoreactivity. Withdrawal of conditioned growth media and culture in serum-free medium results in OL-1 cell maturation, manifested by a shift to myelin basic protein-positive immunoreactivity, A2B5 antigen-negative immunoreactivity, decreased NG2 mRNA expression, increased expression of proteolipid protein mRNA, and increased expression of CNP protein. In addition, the expression of proteolipid protein and its splicing variant DM-20 exhibit a pattern that is similar to brain proteolipid protein expression during development. When OL-1 cells are exposed to Insulin-like growth factor-I, there are significant increases in proteolipid protein mRNA expression (p<0.05), the number of cell processes (p<0.05), and cell number (p<0.05). Treatment with the caspase inhibitors Z-DEVD-FMK and Z-VAD-FMK (inhibitors of caspases 3, 6, 7, 8, 10 and 1, 3, 4, respectively), Insulin-like growth factor-I, or both, results in a similar increase in cell number. Because Insulin-like growth factor-I does not substantially increase the BrdU labeling of OL-1 cells, these data collectively indicate that Insulin-like growth factor-I increases OL-1 cell number predominately by promoting survival, rather than stimulating proliferation. This non-immortalized oligodendrocyte precursor cell line, therefore, exhibits behavior consistent with the in vivo development of oligodendrocytes and provides an excellent model for the study of developing oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306496      PMCID: PMC2302791          DOI: 10.1016/j.ijdevneu.2006.12.006

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  36 in total

Review 1.  Gliogenesis in the central nervous system.

Authors:  J C Lee; M Mayer-Proschel; M S Rao
Journal:  Glia       Date:  2000-04       Impact factor: 7.452

2.  A novel oligodendrocyte cell line OLP6 shows the successive stages of oligodendrocyte development: late progenitor, immature and mature stages.

Authors:  T Matsushita; Y Amagai; T Soga; K Terai; M Obinata; S Hashimoto
Journal:  Neuroscience       Date:  2005-09-21       Impact factor: 3.590

3.  A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium.

Authors:  M C Raff; R H Miller; M Noble
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

4.  Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury.

Authors:  P Ye; A J D'Ercole
Journal:  Endocrinology       Date:  1999-07       Impact factor: 4.736

5.  Hypoxia-ischemia induces DNA synthesis without cell proliferation in dying neurons in adult rodent brain.

Authors:  Chia-Yi Kuan; Aryn J Schloemer; Aigang Lu; Kevin A Burns; Wei-Lan Weng; Michael T Williams; Kenneth I Strauss; Charles V Vorhees; Richard A Flavell; Roger J Davis; Frank R Sharp; Pasko Rakic
Journal:  J Neurosci       Date:  2004-11-24       Impact factor: 6.167

6.  Myelination is altered in insulin-like growth factor-I null mutant mice.

Authors:  Ping Ye; Liqin Li; R Gregg Richards; Richard P DiAugustine; A Joseph D'Ercole
Journal:  J Neurosci       Date:  2002-07-15       Impact factor: 6.167

7.  Expression of myelin protein genes and other myelin components in an oligodendrocytic cell line conditionally immortalized with a temperature-sensitive retrovirus.

Authors:  A N Verity; D Bredesen; C Vonderscher; V W Handley; A T Campagnoni
Journal:  J Neurochem       Date:  1993-02       Impact factor: 5.372

8.  Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.

Authors:  K D McCarthy; J de Vellis
Journal:  J Cell Biol       Date:  1980-06       Impact factor: 10.539

9.  Quantitative assay for measuring the Taura syndrome virus and yellow head virus load in shrimp by real-time RT-PCR using SYBR Green chemistry.

Authors:  Arun K Dhar; Michelle M Roux; Kurt R Klimpel
Journal:  J Virol Methods       Date:  2002-06       Impact factor: 2.014

10.  Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice.

Authors:  M Fruttiger; L Karlsson; A C Hall; A Abramsson; A R Calver; H Boström; K Willetts; C H Bertold; J K Heath; C Betsholtz; W D Richardson
Journal:  Development       Date:  1999-02       Impact factor: 6.868

View more
  6 in total

1.  beta-catenin mediates insulin-like growth factor-I actions to promote cyclin D1 mRNA expression, cell proliferation and survival in oligodendroglial cultures.

Authors:  Ping Ye; Qichen Hu; Hedi Liu; Yun Yan; A Joseph D'ercole
Journal:  Glia       Date:  2010-07       Impact factor: 7.452

2.  Conditional Tet-regulated over-expression of Hoxa2 in CG4 cells increases their proliferation and delays their differentiation into oligodendrocyte-like cells expressing myelin basic protein.

Authors:  Monica Wang; J Ronald Doucette; Adil J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2011-04-09       Impact factor: 5.046

3.  Histone deacetylase 11 regulates oligodendrocyte-specific gene expression and cell development in OL-1 oligodendroglia cells.

Authors:  Hedi Liu; Qichen Hu; A Joseph D'ercole; Ping Ye
Journal:  Glia       Date:  2009-01-01       Impact factor: 7.452

Review 4.  Expanding the mind: insulin-like growth factor I and brain development.

Authors:  A Joseph D'Ercole; Ping Ye
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

Review 5.  Behavioral experiences as drivers of oligodendrocyte lineage dynamics and myelin plasticity.

Authors:  Lyl Tomlinson; Cindy V Leiton; Holly Colognato
Journal:  Neuropharmacology       Date:  2015-09-28       Impact factor: 5.250

Review 6.  Hormonal Regulation of Oligodendrogenesis I: Effects across the Lifespan.

Authors:  Kimberly L P Long; Jocelyn M Breton; Matthew K Barraza; Olga S Perloff; Daniela Kaufer
Journal:  Biomolecules       Date:  2021-02-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.